Abstract. It has been thought that adipocytes lack proliferative ability and do not revert to precursor cells. However, numerous findings that challenge this notion have also been reported. The idea that adipocytes dedifferentiate to fibroblastlike cells with increasing cell number was reported in 1975. This possibility has been ignored despite knowledge gained in the 1990s regarding adipocyte differentiation. Several studies on proliferation and dedifferentiation of adipocytes have been published, most of which were conducted from the perspective of regenerative medicine. However, the concept of proliferation of adipocytes remains unclear. In this study, we postulate a new population of adipocytes, which consist of small sized cells (less than 20 µm in diameter) expressing adipocyte markers, such as adiponectin and peroxisome proliferator-activated receptor γ (PPARγ), but not possessing large lipid droplets. These cells show marked ability to incorporate 5-bromo-2′-deoxyuridine (BrdU), for which reason we termed them "small proliferative adipocytes (SPA)". In addition, SPA are observed in the stromal vascular fraction. Since SPA are morphologically different from mature adipocytes, we regarded them as committed progenitor cells. When proliferation of adipocytes in vivo is assessed by measuring BrdU incorporation and expression levels of proliferating cell nuclear antigen (PCNA) in isolated fractions of adipocytes from adipose tissues, subcutaneous SPA proliferate less actively than visceral SPA. Treatment with pioglitazone increases the number of proliferating SPA in subcutaneous, but not visceral, fat, suggesting that SPA may be important in regulating systemic insulin sensitivity and glucose metabolism.
Proliferation and Dedifferentiation of Adipocytes
The notion that the cell number of adipocytes is fixed [1] has been denied by the observation that adipose tissue grows by an increase in both cell number and cell size [2] . The basic methods for measurement of adipocyte size was established first by Hirsch and Gallian [3] . They recommended the use of a Coulter counter to count cells in a suspension derived from a tissue and subjected to osmium tetroxide fixation. Progress in tissue culture technique has provided new insights into precursor cells of adipocytes. Stromal fibroblasts from adipose tissue were termed preadipocytes by Poznanski et al., in 1973 [4] . The authors stated that lipid-filled adipocytes did not divide. Interestingly, Adebonojo described cell division and dedifferentiation in cultured adipocytes in the same period [5] . He reported that primary cultured adipocytes divided while changing 11], although oddly enough, the idea of proliferation of adipocytes was ignored. Articles focusing on adipose tissue growth had described that newly formed adipocytes were equivalent to adipocytes newly differentiated from preadipocytes, and so few review articles noted the possibility of the proliferation of adipocyte [12] .
In 1996, Zhang et al. reported that expression of PPARγ is required to maintain the phenotype of mature adipocytes [13] . They showed that down-regulation of PPARγ by TNFα resulted in dedifferentiation in 3T3-L1 adipocytes. To our knowledge, this is the initial article to explain the mechanism of dedifferentiation of adipocytes at the cellular signaling level. Although many authors consider the differentiation process in adipocytes to be irreversible [14] , evidence of the dedifferentiation of adipocytes has accumulated. Many researchers have investigated the use of dedifferentiated cells as a source of multipotent stem cells [15] [16] [17] [18] [19] [20] [21] . Recently, these cells are named dedifferentiated fat (DFAT) cells. Major studies of dedifferentiation of adipocytes listed in Table 1 (review articles and articles extremely focused on regenerative medicine were excluded) were carried out using ceiling culture. Interestingly, the possibility of the proliferation of adipocytes has been excluded in the research of adipocytes, However, most of these articles described from the point of regenerative medicine have shown that the proliferation of adipocytes was associated with dedifferentiation. Numerous authors have shown that DFAT shows identical gene expression to that of SVF-derived mesenchymal stem cells [17, 18] . A more recent study has revealed that it exhibits similar gene expression and DNA methylation condition to those of bone marrow-derived stem cells [20] . Most of these studies were performed using ceiling culture, which was first proposed by Sugihara et [9] .
In the 1990s, epoch-making progress was made in the research on adipocytes. The discovery of PPARγ provided the molecular bases in the process of differentiation of adipocytes. Moreover, recognition that activation of peroxisome proliferator-activated receptor γ (PPARγ) by thiazolidinedione leads to improvement of insulin resistance and hyperglycemia, stimulated research in this area. On the other hand, the discovery of leptin was followed by the finding of various hormones, including adiponectin, resistin, PAI-1, RBP4 and visfatin, and cytokines such as TNFα, IL6, IL10, and MCP-1, secreted by adipocytes, which are named adipokines. These achievements dramatically increased the understanding of adipocyte biology [10, [23] to study adipose tissue regeneration [21] . Furthermore, Wnt-but not TNFα-induced dedifferentiation of adipocytes was accompanied by cell division [22] . In addition, Tejerina et al. have claimed that two mechanisms, the PPARγ-dependent and the PPARγ-independent signaling pathways, are involved in the dedifferentiation of adipocytes [23] . These results indicate that dedifferentiation and proliferation are observed simultaneously. However, very little is known about the relationship between dedifferentiation and proliferation.
Recently, the number of adipocytes has been determined using various methods. Jo et al. estimated the number of adipocytes based on cell-size distribution, in adipose tissue using a Coulter Multisizer and mathematical model [24] . The resulting increased number of adipocytes was regarded to reflect newborn adipocytes differentiated from preadipocytes. On the other hand, Spalding et al. estimated human adipocyte turnover by exploiting the incorporation of atmospheric 14 C into DNA [25] . These methods were based on the assumption that adipocytes do not replicate and die. Therefore, whether this assumption is appropriate should be reviewed further.
New Concept of Proliferation and Differentiation of Adipocytes
Taking the above findings together, we are skeptical about the conventional view (Fig. 1A ) that terminal differentiation of adipocytes accompanied by the expression of PPARγ and C/EBP proteins is tightly associated with permanent growth arrest. In general, an exit from the cell cycle is thought to be indispensable to differentiation in all types of cells [26] , although opposite views have also been expressed [27] . Terminal differentiation of adipocytes is thought to be initiated by contact inhibition-induced growth arrest, but the necessity of growth arrest has been controversial. Guo et al. demonstrated that contact inhibition-induced DNA methylation was necessary for further differentiation, while cell division following contact inhibition did not attenuate differentiation in 3T3-L1 adipocytes [28] . However, such findings raise the question of what causes contact inhibition in adipose tissue in vivo. On the other hand, C/EBPα is suggested to play an important role in terminating cell proliferation during adipo-
Fig. 1 Schematic presentation of differentiation, proliferation and dedifferentiation of adipocytes
A: The conventional concept that differentiation of adipocytes is irreversible and that adipocytes lose proliferative ability on entering terminal differentiation. B: The concept discussed in this article. Upon unknown stimulation, preadipocytes start to differentiate into adipocytes. Small adipocytes presenting adipocyte markers and having tiny or no fat droplets (SPA) continue to replicate. The proliferative ability is lost in the process of further differentiation. Whether large adipocytes turn into SPA or dedifferentiate directly into preadipocytes is unknown. C: Mature adipocytes directly dedifferentiate into preadipocyte, whereas whether mature adipocytes convert into SPA, or SPA convert into preadipocytes, is unknown.
ing in buffer are attached onto a glass slide, and dried to prepare a smeared adipocyte specimen (smeared adipocytes, Fig. 2D-I ). Ceiling culture is applicable for this purpose. Isolated adipocytes are poured into a gelatin coated Lab-Tec Flaskette filled with DMEM. The bottle is placed upside-down for 24 hr (Fig. 3A) . Adipocytes can be observed as monolayer cells (Fig. 3B-D) . Numerous small cells are observed in these specimens as shown in Figs. 2D-I and 3B. The question arises whether these cells are small adipocytes or nonadipocyte contaminants. Immunocytochemical study reveals that mature adipocyte markers such as PPARγ and adiponectin are detected in most of these small cells (less than 20 µm in diameter) (2D, F, G-I). Isolated adipocytes ceiling cultured for 1 day exhibits a vast diversity of cell sizes (Fig. 3B) . The size distribution of these cells is bimodal (Fig. 3E) , suggesting that cells less than 20 µm may be functionally different from larger cells. More than 90% of the BrdU-labeled nuclei are observed in small adipocytes (Fig. 3E, F) and only a small portion of BrdU-positive nuclei are in large adipocytes (more than 30 µm in diameter). Taken together, small adipocytes exhibit proliferative activity. Although these cells express adipocyte markers, they are different from typical mature adipocytes possessing large lipid droplets. Hence, we regarded them as a new population of adipocytes, which we named small proliferative adipocytes (SPA). It is noteworthy that 5-10% of the cells in SVF were positive for adiponectin and Glut4 (Fig. 3G,  H) . This indicates that adipocyte specific gene expression precedes fat accumulation. We assume that these sinking cells expressing adiponectin and Glut4 are SPA that accumulate very low amounts of fat. Our preliminary study suggested that isolated SPA in SVF in culture medium formed small colonies (data not shown). Since ceiling-cultured adipocytes including SPA do not form colonies, this would suggest that SPA in SVF are perhaps in a less differentiated stage. However, we have no information as to whether all preadipocytes differentiate into mature adipocytes via SPA. The next issue is whether large adipocytes are able to replicate. Although a small proportion of adipocytes more than 30 µm in diameter incorporate BrdU, their number is very small. Considering the fact that the amount of lipid accumulation varies among SPA, from sinking cells to floating ones, BrdU-positive medium sized-adipocytes (30-60 µm in diameter) are speculated to be a variant of SPA. Elucidation of specific markers of SPA will help to discriminate SPA from mature adipocytes in medium-sized genesis [29] . However, as fibroblasts from C/EBPα-deficient mice undergo adipose differentiation through activation of PPARγ [30] , the significance of growth arrest in adipogenesis remains unclear.
Here we propose a new concept of proliferation and differentiation of adipocytes as shown in Fig. 1B . Upon unknown stimulation, preadipocytes enter the program to express transcription factors such as CEBP/β, PPARγ and C/EBPα. These cells then express adipocyte specific proteins including adiponectin, leptin and Glut4, and start to accumulate lipid, although the cell diameter rarely exceeds 20 µm. Cell proliferation continues in these small adipocytes, with this potency being lost when the cell size exceeds a certain limit. Presumably, terminal differentiation may proceed subsequently in parallel with an increase in cell size. These small adipocytes displaying proliferative activity are a newly identified population, which we named "small proliferative adipocytes (SPA)". On the other hand, mature adipocytes are able to dedifferentiate into preadipocytes, as described above (Fig. 1C) . The idea is based on the observation of adipocytes in vivo as described below.
Immunohistochemical Study
Proliferation of adipocytes can be evaluated with an immunohistochemical method using antibodies against proliferation markers such as anti-5-bromo-2′-deoxyuridine (BrdU), anti-proliferating cell nuclear antigen (PCNA) and anti-Ki67 antibodies. Foster and Bartness showed that adipocytes incorporate BrdU [31] . As reported by Foster and Bartness BrdU-labeled nuclei of adipocytes, as well as PCNA-labeled ones, are observed in paraffin-embedded adipose tissue sections ( Fig. 2A, B) . The most serious disadvantage of this method is that discrimination between adipocytes and non-adipocytes is often difficult. In addition, BrdU-or PCNA-labeled cells do not distribute uniformly, making this method unsuitable for quantification.
Immunocytochemical Study
It is not always easy to identify adipocytes accurately in adipose tissue specimen. To overcome this, we developed an immunocytochemical method using isolated adipocytes [32] . To assess the purity of isolated adipocytes, we attempted to observe individually dispersed cells. As shown in Fig. 2C , isolated adipocytes float-fferentiation of adipocytes. As shown in Fig. 3I , dedifferentiating cells observed in ceiling culture exhibited spindle shape with multiple lipid droplets. Although it is unknown whether SPA undergo dedifferentiation, this figure indicates that mature adipocytes directly dedifferentiate into preadipocytes (Fig. 1C) .
Assessment of Proliferation of Adipocytes in Adipose Tissue
Adipocyte number has been evaluated by various methods as described above. We assessed proliferation of adipocytes with replicating cell markers. First, we measured BrdU incorporation into DNA of isolated adipocytes (dot blot analysis) [32] . Since the amount of incorporated BrdU is expressed based on the amount of DNA, comparisons between other cell types, for cells. A ceiling culture experiment in our previous study revealed neonate cells only around small adipocytes [32] . Therefore, proliferative potency is considered to be restricted to SPA. In other words, growth arrest may take place in the next stage of SPA. A similar phenomenon is observed in hepatocyte differentiation. In primary culture of non-parenchymal cells of the liver, small hepatocytes, which were less than half the size of mature hepatocytes, were identified. They actively proliferate and simultaneously express hepatocyte markers such as albumin, transferrin, CK8 and CK18. Therefore, small hepatocytes are regarded as "committed progenitor cells" [33] . SPA may also be considered as committed progenitor cells in adipocyte lineage. On the other hand, several studies have demonstrated that dedifferentiation of adipocytes is associated with proliferation as described above [5, 9, 17, 18, 22] . We have few data on the dedi- but not visceral fat in rats [32] . The expression levels of PCNA in subcutaneous, epididymal and mesenteric adipose tissues were similar to the results of dot blot analysis. These methods in principle are the same as [
3 H]thymidine incorporation in vivo. The most critical point is the possibility of non-adipocyte contamination. As described above, Klyde and Hirsch carefully excluded this possibility [7] . Actually, the number of rinses of isolated adipocytes (1, 3 and 5 rinses) did not influence the expression level of PCNA (Fig. 4C) . Taken together, detected PCNA levels represent proliferation of adipocytes. Expression levels of PCNA were elevated in visceral as compared with subcutaneous example adipocytes and SVF, are easily performed. As shown in Fig. 4A , we found that visceral adipocytes, epididymal, mesenteric and perirenal adipocytes incorporate BrdU more actively than subcutaneous ones. Moreover, BrdU incorporation in various adipocytes was equal to, or even greater than SVF. This result indicated that BrdU incorporated into adipocytes was not the result of contamination by SVF. Measurement of PCNA with western blot in isolated adipocytes is a simpler method to evaluate proliferation of adipocytes. As shown in Fig. 4B , dot blot analysis revealed that treatment with pioglitazone for 2 weeks resulted in an increase of BrdU incorporation in subcutaneous fat, 
Conclusion
In this review, we discussed the proliferation of adipocytes. It has been thought that the differentiation of adipocytes is irreversible, and associated with the loss of proliferative ability (Fig. 1A) . However, several investigations have demonstrated the plasticity of adipocytes. In this regard, we evaluated the proliferative ability of adipocytes in adipose tissue. We confirmed that small adipocytes do express proliferation markers using certain methods. We termed these cells "SPA", since they apparently differ from typical adipocytes possessing large fat droplets. Although a small number adipocytes (Fig. 4D) . Moreover, pioglitazone administration increased expression levels of PCNA in subcutaneous adipocytes (Fig. 4E) [32] , which is consistent with the results of dot blot analysis. These results explain the mechanism of pioglitazone-induced subcutaneous adipocyte hyperplasia. On the other hand, expression levels of PCNA were elevated in adipocytes isolated from obese rats at 12w of age, which declined to lower levels than those of control rats at 32w of age (data not shown). These data suggest that proliferation of adipocytes is linked to systemic adiposity and insulin sensitivity. A histogram shows the effect of food containing 0% Pio, Control = white bars, 0.005% Pio = black bars and 0.025% Pio = gray bars on BrdU incorporation in various adipose tissues. All values are relative to the level of BrdU incorporation in the subcutaneous adipocyte isolated from the control (100%). n = 6; **, P < 0.01 vs control. C: Western blot representing the expression levels of PCNA in isolated adipocytes rinsed one, three and five times. D: Expression of PCNA protein in subcutaneous, epididymal and mesenteric adipocytes isolated from untreated rats. Sub: subcutaneous, Epi: epididymal, Mes: mesenteric, E: PCNA expression levels in adipocytes of subcutaneous (Sub), epididymal (Epi) and mesenteric (Mes) fat isolated from Control and Pioglitazone (food containing 0.005% pioglitazone) treated rats. Typical results from four separate experiments are shown.
the establishment of a primary culture of isolated SPA is desireable. Futher study is required to better understand the role of SPA in systemic glucose and lipid metabolism.
of medium-sized adipocytes (30-60 µm) incorporated BrdU, they might be a variant of SPA. We assume that SPA may be committed progenitor cells, and that proliferation may be terminated during the process of further differentiation (Fig. 1B) . To clarify these issues,
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